Stock SHL SIEMENS HEALTHINEERS AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Siemens Healthineers AG

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Market Closed - Xetra
Other stock markets
 11:35:11 2024-04-26 am EDT 		5-day change 1st Jan Change
52.94 EUR +1.22% Intraday chart for Siemens Healthineers AG +4.21% +0.65%
Apr. 24 SIEMENS HEALTHINEERS : DZ Bank remains Neutral ZD
Apr. 22 European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations MT

Valuation

Fiscal Period: Settembre 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 36,067 41,088 63,053 49,516 53,731 59,070 - -
Enterprise Value (EV) 1 39,241 45,979 74,121 61,565 68,749 70,772 69,408 67,597
P/E ratio 23 x 27.4 x 35.8 x 24.5 x 35.8 x 28.9 x 23 x 19.1 x
Yield 2.22% 2.09% 1.51% 1.92% 1.98% 1.94% 2.39% 2.68%
Capitalization / Revenue 2.48 x 2.84 x 3.5 x 2.28 x 2.48 x 2.6 x 2.43 x 2.28 x
EV / Revenue 2.7 x 3.18 x 4.12 x 2.84 x 3.17 x 3.11 x 2.85 x 2.6 x
EV / EBITDA 13.4 x 16.4 x 20.5 x 14.4 x 18.6 x 15.2 x 12.9 x 11.3 x
EV / FCF 37.8 x 33.5 x 32.8 x 37.3 x 53.7 x 27.1 x 24.1 x 20.4 x
FCF Yield 2.65% 2.98% 3.05% 2.68% 1.86% 3.69% 4.15% 4.91%
Price to Book 3.69 x 3.07 x 3.79 x 2.51 x 2.96 x 3.12 x 2.9 x 2.69 x
Nbr of stocks (in thousands) 999,223 1,072,798 1,122,335 1,118,252 1,119,394 1,115,788 - -
Reference price 2 36.10 38.30 56.18 44.28 48.00 52.94 52.94 52.94
Announcement Date 11/4/19 11/2/20 11/4/21 11/9/22 11/8/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 14,518 14,460 17,997 21,714 21,680 22,749 24,338 25,949
EBITDA 1 2,920 2,796 3,612 4,269 3,692 4,648 5,380 5,963
EBIT 1 2,300 2,230 3,142 3,655 3,081 3,535 4,150 4,752
Operating Margin 15.84% 15.42% 17.46% 16.83% 14.21% 15.54% 17.05% 18.31%
Earnings before Tax (EBT) 1 2,193 1,954 2,404 2,800 1,928 2,853 3,517 4,179
Net income 1 1,567 1,411 1,727 2,038 1,509 2,050 2,576 3,114
Net margin 10.79% 9.76% 9.6% 9.39% 6.96% 9.01% 10.59% 12%
EPS 2 1.570 1.400 1.570 1.810 1.340 1.832 2.299 2.771
Free Cash Flow 1 1,038 1,371 2,259 1,652 1,281 2,610 2,882 3,317
FCF margin 7.15% 9.48% 12.55% 7.61% 5.91% 11.48% 11.84% 12.78%
FCF Conversion (EBITDA) 35.55% 49.03% 62.54% 38.7% 34.7% 56.16% 53.56% 55.62%
FCF Conversion (Net income) 66.24% 97.17% 130.8% 81.06% 84.89% 127.32% 111.85% 106.53%
Dividend per Share 2 0.8000 0.8000 0.8500 0.8500 0.9500 1.025 1.265 1.419
Announcement Date 11/4/19 11/2/20 11/4/21 11/9/22 11/8/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 5,164 5,068 5,460 10,528 5,186 6,000 5,077 5,346 5,201 6,056 5,176 5,457 5,521 6,486 - -
EBITDA 1 - - 1,116 - 938 1,211 - - - - 885 1,037 1,091 1,366 - -
EBIT 1 793 898 980 1,879 765 1,011 647 681 740 1,013 742 856.8 874.9 1,202 - -
Operating Margin 15.36% 17.72% 17.95% 17.85% 14.75% 16.85% 12.74% 12.74% 14.23% 16.73% 14.34% 15.7% 15.85% 18.53% - -
Earnings before Tax (EBT) 1 - 661 - - - - - - - - 543 574.7 637.4 865.7 - -
Net income 1 462 466 579 - 363 630 421 105 451 537 431 538.3 544.2 644.1 - -
Net margin 8.95% 9.19% 10.6% - 7% 10.5% 8.29% 1.96% 8.67% 8.87% 8.33% 9.86% 9.86% 9.93% - -
EPS 2 0.4100 0.4100 0.5100 - 0.3200 0.5600 0.3800 0.4700 0.4000 0.4800 0.3800 0.4735 0.4787 0.5867 - -
Dividend per Share 2 0.8500 - - - - 0.8500 - - - 0.9500 - - - 1.053 - -
Announcement Date 11/4/21 2/3/22 5/4/22 5/4/22 8/3/22 11/9/22 2/2/23 5/16/23 8/2/23 11/8/23 2/1/24 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,174 4,891 11,068 12,049 15,018 11,702 10,338 8,527
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.087 x 1.749 x 3.064 x 2.822 x 4.068 x 2.518 x 1.921 x 1.43 x
Free Cash Flow 1 1,038 1,371 2,259 1,652 1,281 2,610 2,882 3,317
ROE (net income / shareholders' equity) 17% 14.3% 15.5% 14.3% 12.8% 13.2% 14.8% 15.7%
ROA (Net income/ Total Assets) 7.61% 6.07% 6.64% 5.65% 4.72% 4.82% 5.76% 6.48%
Assets 1 20,594 23,262 26,009 36,049 32,002 42,566 44,760 48,082
Book Value Per Share 2 9.790 12.50 14.80 17.70 16.20 17.00 18.20 19.60
Cash Flow per Share 2 1.620 1.910 2.670 2.220 1.880 3.310 3.480 3.830
Capex 1 579 557 674 852 838 922 957 1,030
Capex / Sales 3.99% 3.85% 3.75% 3.92% 3.87% 4.05% 3.93% 3.97%
Announcement Date 11/4/19 11/2/20 11/4/21 11/9/22 11/8/23 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Siemens Healthineers AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
52.94 EUR
Average target price
60.33 EUR
Spread / Average Target
+13.96%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
RESMED, INC. Stock ResMed, Inc.
+26.76% 32.03B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. SHL Stock
  4. Financials Siemens Healthineers AG